Amesite Inc.AMST
Price (close)
$1.04
Market cap
$6.8M
P/E
—
Revenue (TTM)
$364,777
Net income
-$3.1M
Dividend yield
—
1-year total return
-66.9%
Net margin
-848.7%
Revenue growth
230.2%
Debt / equity
—
What Amesite Inc. does.
and commercializing AI (artificial intelligence)-powered solutions for the enterprise and for professionals, with particular emphasis
on the post-acute healthcare market. In fiscal 2026, we launched a census-based Enterprise tier with EMR (electronic medical records)
compatibility, automated interdisciplinary team reporting, and configurable documentation; introduced the AI-native NurseMagic™
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | $674,580 | $697,001 | $845,009 | $166,881 | $110,459 | $364,777 |
| Net income | -$11.6M | -$9.1M | -$4.2M | -$4.4M | -$3.6M | -$3.1M |
| Free cash flow | -$5.4M | -$6.7M | -$3.3M | -$2.8M | — | -$2.2M |
More on AMST.
- Amesite Inc. summary
- Amesite Inc. financial statements
- Amesite Inc. key metrics
- Amesite Inc. health scores and style box
- Amesite Inc. earnings
- Amesite Inc. dividends
- Amesite Inc. valuation
- Amesite Inc. ownership and insiders
- Amesite Inc. peers
Figures from Amesite Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.